International Academy of Obstetrics & Gynecology

Home       |

Admissions      |

Tuition Fees    |

Calendar      |

Accreditation  |

Curriculum     |

Staff         | 

Contact

International Academy of
Obstetrics & Gynecology

(Établissement d’Enseignement Supérieur Privé)

Division of the Institute of Pharmacy, Paris
2, Square de Robiac 75007 Paris, France

White Geissler and Associates Shield Logo

Master of Science (MSc) in Obstetrics & Gynecology

(Diplôme Supérieur en Obstétrique et Gynécologie)

STAFF

DR. PETER GEISSLER, MD, PhD

I, Dr. Peter Scott Geissler, MD, PhD, am a licensed physician, board-certified medical physicist in Ireland, authorized medical physicist per United States Nuclear Regulatory Commission Statute § 35.57, and hold the following professional qualifications. licenses, and titles.

1. I have completed studies in physics & engineering, as follows:

Year

Degree

Course

2015BASLand Surveying / Geomatics
Department of Land Surveying / Geomatics
Great Basin College, Nevada
1993PhDCivil Engineering
Department of Civil Engineering
University of California, Irvine
1991MS (Eng)Civil Engineering
Department of Civil Engineering
University of California, Irvine
1988MEng (Civil)Civil Engineering
Department of Civil Engineering
University of California. Davis
1986BSc (Eng)Civil Engineering
Depart1ment of Civil Engineering
Stanford University
1978BAI (Civil)Civil Engineering
Department of Civil Engineering
Trinity College, Dublin, Ireland
1978LCE (Civil)Civil Engineering
Department of Civil Engineering
Trinity College, Dublin, Ireland
1971ABPhysics Department of Physics
University of California, Berkeley
 
NOTE: In 1978, Dr. Geissler took the Trinity College exams in civil engineering which included exams in quantity surveying and building construction technology. The exams were administered by a special committee of the Institution of Civil Engineers of Ireland for the specific purpose of evaluating the equivalency of Dr. Geissler’s USA education in engineering to that of Irish graduates. The proctor who administered the written exams was Prof. Ian Roberts, the Trinity College Architect. Based on these examinations, the degree Baccalaureus in Arte Ingenaria (BAI) and the Licence in Civil Engineering (LCE) were conferred on Dr. Geissler by Trinity College. Based on written exams in structural engineering in 1978, Dr. Geissler was named Chartered Engineer” by the Civil Engineers of Ireland. Based on a viva voce in structural engineering in 1989, Dr. Geissler was named “Fellow of the Institution of Engineers of Ireland” (FIEI) in structural engineering by the Institution of Engineers of Ireland. In 1989, Dr. Geissler was granted the title “European Engineer” (EUR ING) in structural engineering by the European Federation of National Engineering Associations (FEANI Registration Number 019551E).]
 
2. I have completed studies in psychology, biology, physiology, biophysics & medicine, as follows:
 

Year

Degree

Course

2011PhDClinical Psychology
Department of Clinical Psychology
California Institute or Human Science
1997MPhil (Cantab)Biological Sciences
Department of Anatomy
University of Cambridge
1995MDGrace University
School of Medicine
Saint Kitts-Nevis
1995MSAmerican University of the Caribbean
School of Graduate Studies
Montserrat, British West Indies
1978MABiophysics
Department of Biophysics and Medical Physics
University of California, Berkeley
1974PhDPhysiology
Department of Physiology
Yale University
1973MPhilPhysiology
Department of Physiology
Yale University
1972MSPhysiology
Department of Physiology
Yale University

3. I have been granted licenses, registrations, certifications and authorized titles in the fields of engineering, radiation physics & health physics as follows:

  • Registered Professional Land Surveyor – State of Colorado, License No. 38660
  • Certified Water Right Surveyor – State of Idaho
  • Registered Land Surveyor-in-Training – State of Nebraska
  • Registered Professional Engineer – State of Colorado, License No. 57853
  • Registered Professional Civil Engineer – State of Rhode Island, Registration No. 13703
  • Registered Professional Engineer – State of New Mexico, License No. 26051
  • Registered Professional Civil Engineer – Italy, License No. 39070 (Ingegnere iscreto a settori Civile e Ambientale No. 39070)
  • Title Authority: Qualified Expert – State of Utah Division of Waste Management and Radiation Control (Ref: Utah Code Annotated 1953, Section 19-3-104 and pursuant to R313-16-293)
  • Title Authority: Qualified Expert – State of West Virginia (Ref: West Virginia Radiological Health Rule 64csr23 page 8 section 3.67)
  • Title Authority: Radiation Producing Machine or Device Installer or Service Company – State of Nevada, License 00-00-13980-01
  • Registered Professional Radiation Services – State of Massachusetts, License No. 65-0793
  • Registered Professional Radiation Services – District of Columbia, License No. RP0600004
  • Registered Health Physics Consultant – District of Columbia Certificate No. RP0600004
  • Registered Radiation Physicist – District of Columbia Certificate No. RP0600004
  • Registered Professional Qualified Expert – State of Utah, License No. DRC-2020-016050
  • Registered Professional Radiation Physics Services – State of Rhode Island, License No. RPS0227
  • Registered Professional Industrial Safety Consultant – State of New Mexico, License No. 1286-6I
  • Registered Professional Shielding Design – State of Arizona, License No. 2418
    Perit Arkitett u Inġinier Ċivili – Republic of Malta, Warrant No. W980
  • Registered Professional Engineer (Structural, Civil & Structural, Mechanical) – State of Wyoming, License No. PE17744
  • Registered Professional Engineer (Civil & Mechanical) – State of Idaho, License No. P18446
  • Registered Professional Land Surveyor – State of Idaho, License No. L18446
  • Registered Professional Civil Engineer – State of California, License No. 44320
  • General Engineering Contractor – State of California, License No. 464570
  • Registered Professional Civil Engineer – State of Washington, License No. 219112
  • Licensed Professional Land Surveyor – State of Nevada, License No. 025633
  • Licensed Water Rights Surveyor – State of Nevada, License No. 1336
  • Licensed Civil Engineer – State of Nevada, License No.025633
  • Registered Professional Mechanical Engineer – State of Washington, License No. 21911
  • Registered Radiation Physicist – District of Columbia, Certificate No. RP0600004
  • Registered Professional Engineer – State of Tennessee, License No. 0113950
  • Licensed Land Surveyor – State of Wisconsin, License No. 3183
  • Registered Professional Civil Engineer – Virgin Islands, License No. 1349-CE (PE 1349-E/0-37622)
  • Registered Professional Land Surveyor – Virgin Islands, License No. 1349-LS (1393-E / 37622-1B)
  • Licensed Land Surveyor – Commonwealth of the Northern Marianas Islands No. LS-24 (No. PS 34)
  • Registered Professional Engineer & Fellow – Institution of Engineers of Ireland, License No. P474171
  • Eur.Ing. – Fellow of the European Federation of National Engineering Associations (FEANI), Registration No. 01955IE
  • Registered Professional Land Surveyor – State of Maryland, License No. 21943
  • Registered Professional Civil Engineer – State of Florida, License No. 89118
  • Registered Professional Engineer & Land Surveyor – State of Connecticut, License No. PEL.70499
  • Registered Professional Land Surveyor – State of New Mexico, License No. 25336
  • Registered Professional Land Surveyor – State of Arizona, License No. 70421
  • Geometra Laureato – Italy, License No. 11452
  • Provisional Radiation Therapy or Radiologic Imaging – State of Nevada, (Non-provisional License Pending)
  • Registered Professional Qualified Radiation Expert – State of Idaho (License Pending)
  • Registered Professional RPM Installer – State of Nevada, License No. 00-00-13980-01
  • Title Authority: Therapeutic Medical Physicist – U.S. Federal Government pursuant to 10 CFR § 35.51
  • Director, CLIA High Complexity Laboratory, State of Colorado, License No: 06D2192717
  • Director, CLIA High Complexity Laboratory, State of Idaho, License No: 13D2198688
  • Water Right Surveyor – State of Colorado

4. I have been granted licenses, registrations, certifications and authorized titles in the field of medicine, counseling, naturopathy, marriage & family therapy, and psychoanalysis, as follows:

  • Registered Counselor, State of Washington, Registration No. RC00055828
  • Registered Hypnotherapist, State of Washington, Registration No. HP60064991
  • Marriage and Family Therapist Associate, State of Washington, License No. MG60126147
  • Certified Chemical Dependency Professional, State of Washington, License No. CP60058773
  • Marriage and Family Therapist, District of Columbia License No. LMFT000063
  • Registered Addiction Counselor, District of Columbia Registration No. ADD14039
  • Licensed Health Care Provider, State of Tennessee, Department of Health, pursuant to Health Care Consumer Right-to-Know Act of 1998, T.C.A. § 63-51-101, et seq.)
  • Marital and Family Therapist, State of Tennessee, Certificate No. 309104
  • Licensed Alcohol and Drug Abuse Counselor, State of Tennessee, License No. 1059
  • Certified Clinical Therapist, State of Oregon, License No. 10129152
  • Mental Health Counselor, State of Florida, License No. MH8935
  • Registered Naturopath, District of Columbia Registration No. NAT100739
  • Certified Drug, Alcohol & Addictions Counselor, State of California, Certification No. 100610
  • Registered Addiction Counselor, State of California, Certification No. G0607301333
  • Registered Research Psychoanalyst, State of California, California Medical Board, Registration No. RP 222
  • Licensed Medical Doctor Zanzibar, Medical Council Reg. No. P/MDF/0002
  • Title Authority: Sex Offender Treatment Provider – State of Washington, pursuant to RCW 18.155.020 (4)
  • Title Authority: Mental Health Professional – State of Washington by the Department of Social and Health Services, Division of Behavioral Health and Recovery, pursuant to WAC 388-865-0150 (3) and pursuant to the waiver criteria of RCW 71.24.2600
  • Title Authority: Geriatric Mental Health Specialist – State of Washington by the Department of Social and Health Services, Division of Behavioral Health and Recovery, pursuant to WAC 388-865-0150

5. I have been approved as a court-appointed civil mediator in the following jurisdictions:

  • General Civil Mediator, Sixth Appellate District Court of Appeal, State of California
  • General Civil Mediator, United States District Court, District of Idaho
  • General Civil Mediator, United States District Court for the Western District of Pennsylvania
  • Civil Mediator, Superior Court of California, County of Amador
  • Civil Mediator, Superior Court of California, County of Contra Costa
  • General Civil Mediator / Rule 31 Neutral, State of Tennessee, Supreme Court of Tennessee
  • Civil Mediator, Superior Court of California, County of Fresno
  • Civil Mediator, Superior Court of California, County of Yolo
  • Civil Mediator, Superior Court of California, County of Solano
  • Family Mediator / Rule 31 Neutral, State of Tennessee, Supreme Court of Tennessee
  • Appellate Mediator / Rule 37 Neutral, State of Tennessee, Court of Appeals for Worker’s Compensation Appeals
  • General Civil Mediator / Registered Neutral, State of Georgia, Supreme Court of Georgia, Registration No. 35850
  • Civil Mediator, Superior Court of California, County of Butte
  • Civil Mediator, Superior Court of California, County of Nevada
  • Civil Mediator, Superior Court of California, County of Tuolume

6. I am an intellectual property attorney (patents, trademarks & designs) in Malta with authority to represent clients before the Commerce Department, Intellectual Property Office Malta. Accordingly, I am listed on the Intellectual Property Office Malta website. [Ref: https:/secure2.gov.mt/ipo/Intellectual Property Office Malta/List%20of%201P%20Attormeys.aspx?ct=l]

7. My primary qualification as an intellectual property attorney in Malta has been recognized by the Irish Patents Office pursuant to The European Communities (Recognition of Professional Qualifications) Regulations 2007.

8. I have been granted permission to authenticate electronic signatures pursuant to Electronic Commerce Subsidiary Legislation made under s. 25, Approval of Providers of Accreditation Certificates Regulations 2013/066 Rule 2, Schedule 1 (Gibraltar).

9. I am licensed to issue acknowledgements, jurats and certifications and to perform certain other restricted activities such as taking depositions and sworn statements in the State of California pursuant to Government Code 8200-8230, License No. 2058708. [NOTE: This is comparable to Commissioners for Oaths in Ireland and Her Majesty’s governments in Gibraltar and the United Kingdom pursuant to Commissioners For Oaths Act 1889.]

10. I am an immigration consultant pursuant to California Business and Professions Code Sections 22440-22448.

11. I am a non-attorney representative for the prosecution of claims, redeterminations, reconsiderations, hearings and appeals before the Social Security Administration pursuant to applicable federal law. [Ref: (i) 8 U.S.C. §§ 203, 205, and 207; and 42 U.S.C. §§ 406 (a), 1320a-6, and 1383(d)(2); (ii) 20 CFR §§ 404.1700 et seq., 408.1101, and 416.1500 et seq.; (iv) Social Security Rulings 83-27 and 82-39; and (v) 6 U.S.C. §§ 6041 and 6045(f).]

12. I am a non-attorney Medicare claims representative pursuant to Title XVIII of the Social Security Act and related provisions of Title XI of the Act.

13. I am a non-attorney representative in hearings before the San Francisco Rent Control Board pursuant to Chapter 37 of the San Francisco Administrative Code, The Residential Rent Stabilization And Arbitration Ordinance.

14. I have been appointed Commissioner for Oaths by the Supreme Court of Gibraltar pursuant to the Commissioners for Oaths & Public Notaries Act; commencement date 12 May 2015; Registration No. 120/15.

I verily believe and hereby confirm that the above statements are true.

PROF. MASSIMO SANTORINI

Current Position

Full Professor, Department of Biology, University of Padua, IT

 

Education

1994     BS in Biology “summa cum laude” and Special Award, University of Torino (Italy)

1996     Master in Biology and Biochemistry, University of Torino (Italy)

2001     Ph.D. in Cellular and Molecular Biology, Open University, London (UK)

 

Professional Experience

1992-1996     Undergraduate student, Department of Biomedical Sciences and Oncology, University of Turin

1996-2001     PhD student, Open University c/o Department of Biological and Technological Research (Dibit), University of Vita e Salute San Raffaele, HSR

2001-2008     Assistant Professor, Faculty of Science, University of Piemonte Orientale “A. Avogadro”

2001-2004     Post-doc fellow, Department of Medical Science, University of Piemonte Orientale “A. Avogadro”

2001-2008     Post-doc fellow, Department of Biochemistry and Biophysics, University of California, San Francisco, UCSF

2008-2014     Assistant Professor and Group Leader at Molecular Biotechnology Center, University of Turin, Italy

2013-2017     Full Professor, Dept of Oncology, KUL and Group Leader, VIB, Belgium

2013-2016

Associate Professor in Molecular Biology and Group Leader at Molecular Biotechnology Center University of Turin, Italy

2016-2017

Full Professor, Dept. of Biotechnology and Health, University of Turin, Italy

Since 2017

Full Professor, Dept. of Biology, University of Padua, Italy

Since 2020

Group Leader, Venetian Institute of Molecular Medicine (VIMM), Padova, IT

 

Research Activities

• Molecular and metabolic basis of health and diseased angiogenesis.
• Cancer metabolism.
• ROS signaling and antioxidants in cardiovascular homeostasis and cancer progression.

 

Patent

• Patent number PCT/EP2011/051738. UBIAD1 for cellular coenzyme Q10 synthesis and
cardiovascular oxidative protection.
• In vivo redox and metabolic endothelial biosensors (submitted).
• UBIAD1 inhibitors UBIAD1i® (under evaluation).

 

International Awards and Honours

2020 ERC-PoC
2015 ERC Consolidator Grant
2014 Odysseus FWO Awards
2010 Marie Curie Reintegration Award and Grant
2008 HFSP Career Developmental Award and Grant
2005 HFSP Long-term fellow
2004 EMBO Long-term fellow

 

Invited Speaker at National or International Meeting

Cardiac regeneration and Vascular Biology, Venice, IT. Cell death and disease, Garda, IT. SFRR
Symposia, Belgrade, SE. GfMVB, Heidelberg, DE. Angiogenesis Gordon Conference, Maine, US. EVBO-ESM Meeting, Maastricht, NL. Fusion Conference in Cell Death, Cell Stress and Metabolism, Puerto Vallarta, ME. Dutch German vascular biology meeting, Amsterdam, NL. European Zebrafish PI Meeting, Trento, IT. 7th Oxidative Stress, Calcium Signaling and TRP Channel World Congress Antalya, Turkey. Dutch German Vascular Biology meeting, Amsterdam, NL. International Munich ROS Meeting, Munich, DE. APVBO Guangzhou, China. Cardiovascular Meeting, ESC, Padua, IT. EMBO Redox Meeting, Moscow, RU. Redox Biology Meeting, Paris, FR. EVBO meeting, Geneva, CH; 10th Zebrafish European Meeting, Budapest, HU. CRISPR-based Genome Engineering Meeting, Leuven, BE; YUM Meeting, Velen, DE; Gordon Conference in Redox Biology, Vermont, USA; Gordon Conference in Endothelial Cell Phenotype, Spain; Cancer Metabolism, San Francisco, USA.Cell Symposia Multifaceted Mitochondria, Chicago, USA; XVII Telethon Convention, Trento, Italy; Angiogenesis: Basi molecolari ed implicazioni terapeutiche VI, Pontignano, Italy; Gordon Conference on Endothelial Cell Behaviour, Rode Island, USA; 8th international CoQ10 conference, Bologna, Italy; 83rd EAS Congress, Glasgow, Scotland.8th International Kloster Seeon Meeting “Angiogenesis”, Seeon, Germany; 4th International Conference on Ophthalmology, Maryland, USA; International Vascular Biology Meeting, Kyoto, Japan; Keystone Symposia on Metabolism and Angiogenesis, USA. NAVBO meeting, Vascular Biology, Hyannis, MA, USA; 8th European Zebrafish meeting, Barcelona, Spain; ABCD meeting, Ravenna, Italy; Angiogenesis: Basi molecolari ed implicazioni terapeutiche V, Pontignano, Italy. Vesalius Research Center, VIB, Leuven, Belgium, ABCD meeting, Keynote lecture, Parma, Italy; Fondazione Guido Bernardini, Milano, Italia, Fondazione Guido Bernardini, Milano, Italia; “6th European Zebrafish meeting”, Cardiovascular workshop, Rome, Italy; 1st Italian Zebrafish meeting, Brescia, Italy. Angiogenesis: basi molecolari ed implicazioni terapeutiche III, Pontignano, Italy; FISV meeting, Stem cell and regeneration workshop, Riva del Garda, Italy. Gordon Conference on Endothelial Cell Behaviour, Maine, USA. BaStaG meeting USCF retreat, San Francisco, USA. FISV meeting, workshop on Signal Transduction of Cell Adhesion, Proliferation and Differentiation, Riva del Garda, Italy. FISV meeting, Workshop on Signal Transduction of Cell Adhesion, Proliferation and Differentiation, Riva del Garda, Italy. Structures and Function of Interacting Protein Domains in Signal and Energy Transduction, NATO Conference, Napoli, Italy; ABCD-AGI-SIBBM Conference, S. Giminiano, Italy.

 

Invited lectures at Institute or University

GIGA, Liege, FR; University of Udine, Udine, IT. Linkoping University, Linkoping, Sweden. IBPS, Paris, FR; Karolinska Institute, Stockholm, Sweden. University of Padova, IT. Pasteur Institute, Paris, FR; International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, IT; Institute Curie, Pole de Biologie du Développement et Cancer, Paris, FR; BHF Centre for Cardiovascular Science, University of Edinburgh, UK. Department of Anatomy, University of Basel, CH; Department of Biology, University of Padua, Italy. Department of Molecular Biology, Université de Bruxelles, BE. Department of Biology, University of Milan, Italy; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany; Institute of Molecular Life Sciences Universität Zürich UZH, Swiss; NIH, Bethesda, Maryland, USA; KU Leuven Medical School, Stem Cell Instituut, Leuven, Belgium. IRIBHM- ULB, (Université Libre de Bruxelles), Brussels, Belgium; Lecture, Stazione Zoologica A. Dohr, Napoli, Italy. IFOM-IEO Campus, Milan, Italy; VIB Vesalius Research Center, KU Leuven, Belgium. Yale University, School of Medicine, Cardiovascular Department, USA; University of Bordeaux, France; PARCC retreat, Keynote Lecture, Paris, France. University of Padova, Italy; Cardiovascular Network, Molecular Biotechnology Center, University of Torino, Italy.TIGEM, Napoli, Italy; Seminar, UNITre, Torre Pellice, Italy.Lecture, Stazione Zoologica A. Dohr, Napoli, Italy. Faculty Candidate talk, Albert Einstein – Yoshiva University, New York, USA. PASSUCSF, San Francisco, USA. DISCAFF, University of Piemonte Orientale, Novara, Italy; Department Massimo M. Santoro, PhD of Biology, University of Torino, Italy. Seminar, Regina Elena Cancer Institute, Rome, Italy. Cancer Research UK London Research Institute, London, UK

 

Service to Professional and Academic Organization

Organizer and Chair, 3th Italian Zebrafish Meeting, Naples, IT 2022. Organizer and Chair, 16th
SIBBM Seminar: Frontiers in Metabolic Research, 2021, Padua, Italy. Chair, 11th European
Zebrafish Meeting, Prague, Czech Republic. Organizer and Chair, 1st Italian Zebrafish Meeting,
Pisa, IT. Chair, EVBO Meeting, Maastricht, NL. Chair, International Munich ROS Meeting, Munich, DE. Chair, European Zebrafish PI Meeting, Trento, IT. Chair, 7th Oxidative Stress, Calcium Signaling and TRP Channel World Congress Antalya, Turkey. Organizer and Chair, Genome Engineering and Synthetic Biology, Bruges, BE. Organizer and Chair, 5th International Metabolism Mini Symposium, Leuven, BE. Organizer and Chair, 1st Italian Zebrafish Meeting, Padova, IT. CNR, ERC PI centric event, Rome. IT. PhD committee member in Molecular Life Sciences, IMLS, University of Zurich, CH. VIB Group Leader Committee, BE. Department of Oncology, Council Member, KU Leuven, BE. Chairman, Molecular Basis of Cardiovascular diseases, 36th FEBS Congress, IT. Executive Board Member, Department of Biotechnology, University of Torino, IT. PhD committee in Molecular Biology, Dept of Biology, University of Padua, IT. Organizing committee “6th European Zebrafish meeting”, Rome, IT. Chairman, Cardiovascular session, “6th European Zebrafish meeting”, Rome, IT.

 

Editorial Activities

Editorial Board: Cardiovascular Research (Associate Editor), Frontiers in Cell and Developmental
Biology (Associate Editor), Scientific Reports (Associate Editor), Cancers (Editorial Board Member) Solicited reviewer for: Science, Developmental Cell, Cell Reports, Nature Communications, EMBO Molecular Medicine, ATVB, Cardiovascular Research, Science Signaling, Developmental Biology, Experimental Cell Research, Mechanism of Development, Zebrafish, British Journal of Pharmacology, Science Signaling, PLOS One, Scientific Reports.
Solicited reviewer of grants and Ad Hoc Study Sections for: European Research Council (ERC),
HFSP, Cancer Research UK, EMBO, Welcome Trust, MRC, Swedish Research Council, AICR,
Telethon, AIRC, FWO grant, Italian National Academy of Science, University of Padua, Australian National Grant Association, Czech Science Foundation.

 

Professional memberships

Since 2017     Executive Council Member EVBO

Since 2010     European Vascular Biology Organization (EVBO)

2005-2016     North American Vascular Biology Organization (NAVBO)

2005-2010     American Society Cell Biology (ASCB)

Since 2002     Italian Society of Biochemistry and Molecular Biology (SIBBM)

Since 2000     Italian Association of Biological and Cellular Differentiation (ABCD)

 

Professional memberships

2005-2007     PRIN, Italian Research Council, Italy €150.000

2008-2010     Career Developmental Award HFSP, EU €300.000

2008-2012     Marie Curie International Reintegration Grant, EU €100.000

2010-2013     AIRC grant, Italy €100.000

2011-2013     Telethon GGP101095, Italy €350.000

2013-2016     AIRC IG Grant €400.000

2014-2019     Odysseus Grant, Belgium €800.000

2014-2018     VIB, Belgium €1.5 mio

2015-2018     Italian Ministry of Health, Italy €300.000

2016-2022     ERC Consolidator Rendox 647057, EU €2.0 mio

2017-2020     FWO Grant, Belgium €0.500 mio

2018-2022     AIRC IG Grant €700.000

2021-2022     ERC-PoC 963865, €150.000

2021-2023     Telethon Grant, €238.000

 

List of Publications

Peer-reviewed publications (in reverse chronological order)

  1. Brian G. Coon, Sushma Timalsina, Matteo Astone, Minhwan Chung, Jennifer Fang, Jinah Han, Karen Hirschi, Louis-Eric Trudeau, Massimo M. Santoro, Martin A. Schwartz. Shear stress induction of Klf2 through mitochondrial remodeling. Molecular Cell, submitted.
  2. Roxana E. Oberkersch, Giovanna Pontarin, Matteo Astone, Emiliano Panieri, Marianna Spizzotin, Liasian Arslanbaeva, Giovanni Tosi, Sara Ricciardi, Maria Francesca Allega, Stefano Biffo, Paolo Grumati, Saverio Tardito, and Massimo M. Santoro. GLUTAMINOLYSIS AND TRANSAMINASE CONTROL VEGFR2 TRANSLATION DURING ANGIOGENESIS. Nature Metabolism, 2021 in revision.
  3. Nicola Facchinello, Matteo Astone, Marianna Spizzotin, Matteo Audano, Enrica Calura, Mihaela Crisan, Nico Mitro, and Massimo M. Santoro. HEMODYNAMIC FORCES CONTROL VASCULAR MYOGENESIS VIA OXIDATIVE PPP-DEPENDENT CONTROL OF ELASTIN. Nature Metabolism, 2021, in 2° revision.
  4. Clair M. Kelley, Nicole O. Glenn, Dafne Gays, Massimo M. Santoro, and Wilson K. Clements. SCLEROTOME-DERIVED VASCULAR SMOOTH MUSCLE PROGENITORS CONTRIBUTE TO THE HAEMATOPOIETIC STEM CELL SPECIFICATION NICHE. Communication Biology, 2020 in revision.
  5. Chiara Camillo§, Nicola Facchinello§, Dafne Gays, Noemi Gioelli, Matteo Astone, Roxana Oberkersch, Chiara Sandri, Giulia Villari, Luca Tamagnone, Donatella Valdembri, Massimo M. Santoro* and Guido Serini*. LATROPHILIN 2 CONTROLS VASCULAR MORPHOGENESIS AND FUNCTION BY INHIBITING ENDOTHELIAL CELL ADHESION AND YAP/TAZ MECHANOSIGNALING. Journal Cell Biology, 2021 in 2° revision. § co-first author, * co-senior and corresponding authors.
  6. Michael Donadon and Massimo M. Santoro. ORIGIN AND MECHANISMS OF SMOOTH MUSCLE CELLS DEVELOPMENT IN VERTEBRATES. Development, 148: dev197384 doi: 10.1242/dev.197384
  7. Matteo Astone and Massimo M. Santoro. TIME TO FIGHT: TARGETING THE CIRCADIAN CLOCK MOLECULAR MACHINERY IN CANCER THERAPY. Drug Discovery Today, 37,101753, 2021.
  8. Nicola Facchinello, Claudio Laquatra, Lisa Locatello, Giorgia Beffagna, Raquel Brañas Casas, Chiara Fornetto, Alberto Dinarello, Laura Martorano, Andrea Vettori, Giovanni Risato, Rudy Celeghin, Giacomo Meneghetti, Massimo Santoro, Agnes Delahodde, Francesco Vanzi, Andrea Rasola, Luisa Dalla Valle, Maria Berica Rasotto, Tiziana Lodi, Enrico Baruffini, Francesco Argenton, and Natascia Tiso. EFFICIENT CLOFILIUM TOSYLATE-MEDIATED RESCUE OF POLG-RELATED DISEASE PHENOTYPES IN ZEBRAFISH. Cell Death & Disease, 12, 100, 2021.
  9. Liasian Arslanbaeva and Massimo M. Santoro. ADAPTIVE REDOX HOMEOSTASIS IN
    CUTANEOUS MELANOMA. Redox Biology, 37, 2020.
  10. Santoro, M. Massimo. THE ANTIOXIDANT ROLE OF NON-MITOCHONDRIAL COQ10: MYSTERY SOLVED! Cell Metabolism, 31(1), 13–15. 2020.
  11. Santoro, M. Massimo, Beltrame M., Panáková D., Siekmann A. F. Tiso, N., Venero Galanternik M., Hyun Min Jung and Brant M. Weinstein. ADVANTAGES AND CHALLENGES OF CARDIOVASCULAR AND LYMPHATIC STUDIES IN ZEBRAFISH RESEARCH. Frontiers in Cell and Developmental Biology, 7, 946, 2019.
  12. Roxana E. Oberkersch and Massimo M. Santoro. ROLE OF AMINO ACID METABOLISM IN ANGIOGENESIS. Vascular Pharmacology, 17-23, 2019.
  13. Thomas Dickmeis, Yi Feng, Maria Caterina Mione, Nikolay Ninov, Massimo Mattia Santoro, Herman P Spaink, Philipp Gut. NANO-SAMPLING AND REPORTER TOOLS TO STUDY METABOLIC REGULATION IN ZEBRAFISH. Frontiers Cell and Developmental Biology, 7, 1-9. 2019.
  14. Dougall Norris and Massimo M. Santoro. BEFORE THE PUMP. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 2763–2764, 2018.
  15. Oliver A. Stone, Mohamed El-Brolosy, Kerstin Wilhelm, Xiaojing Liu, Ana M. Romão, Elisabetta Grillo, Jason K.H. Lai, Stefan Günther, Sylvia Jeratsch, Carsten Kuenne, I-Ching Lee, Thomas Braun, Massimo M. Santoro, Jason W. Locasale, Michael Potente and Didier Y.R. Stainier. LOSS OF PYRUVATE KINASE M2 LIMITS GROWTH AND TRIGGERS INNATE IMMUNE SIGNALING IN ENDOTHELIAL CELLS. Nature Communications 9, 4077-4087, 2018.
  16. Rupel, K., Zupin, L., Colliva, A., Kamada, A., Poropat, A., Ottaviani, G., Margherita Gobbo, Lidia Fanfoni, Rossella Gratton, Massimo M. Santoro, Roberto Di Lenarda , Matteo Biasotto, and Serena Zacchigna. PHOTOBIOMODULATION AT MULTIPLE WAVELENGTHS DIFFERENTIALLY MODULATES OXIDATIVE STRESS IN VITRO AND IN VIVO. Oxidative Medicine and Cellular
    Longevity, 2, 1–11, 2018.
  17. Zulato E., Ciccarese F., Agnusdei V., Pinazza M., Nardo G., Iorio E., Curtarello M., Silic-Benussi M., Rossi E, Venturoli C., Panieri E., Santoro M. Massimo, Quintieri L., Ciminale V, Indraccolo S. LKB1 LOSS IS ASSOCIATED WITH GLUTATHIONE DEFICIENCY UNDER OXIDATIVE STRESS AND SENSITIVITY OF CANCER CELLS TO CYTOTOXIC DRUGS AND g-IRRADIATION. Biochem Pharmacology, 156, 479-490, 2018.
  18. Sanjay Sinha and Massimo M. Santoro. NEW MODELS TO STUDY VASCULAR MURAL CELL EMBRYONIC ORIGIN: IMPLICATIONS IN VASCULAR DISEASES. Cardiovascular Res. 114(4):481- 491, 2018.
  19. Jacoba J. Louw, Ricardo Nunes Bastos, Xiaowen Chen, Céline Verdood, Anniek Corveleyn, Yaojuan Jia, Jeroen Breckpot, Marc Gewillig, Hilde Peeters, Massimo M. Santoro, Francis Barr, Koenraad Devriendt. COMPOUND HETEROZYGOUS LOSS-OF-FUNCTION MUTATIONS IN KIF20A ARE ASSOCIATED WITH A NOVEL LETHAL CONGENITALCARDIOMYOPATHY IN TWO SIBLINGS. PLOS Genetics, 22;14 (1):e1007138, 2018.
  20. Massimo M. Santoro. FASHIONING BLOOD VESSELS BY ROS SIGNALLING AND METABOLISM. Seminars in Cell & Developmental Biology, 80, 35-42, 2018.
  21. Emiliano Panieri, Carlo Milia and Massimo M. Santoro. IN VIVO REAL-TIME MONITORING AND IMAGING OF SUBCELLULAR H202 AND GLUTATHIONE REDOX POTENTIAL IN CARDIOVASCULAR TISSUES. Free Radical Biology and Medicine, 109, 189-200, 2017.
  22. Emiliano Panieri and Massimo M. Santoro. DATA ON METABOLIC-DEPENDENT ANTIOXIDANT RESPONSE IN THE CARDIOVASCULAR TISSUES OF LIVING ZEBRAFISH UNDER STRESS CONDITION. Data in Brief, 12, 427-432, 2017.
  23. Dafne Gays, Christopher Hess, Annalisa Camporeale, Ugo Ala, Paolo Provero, Christian Mosimann and Massimo M. Santoro. AN EXCLUSIVE CELLULAR AND MOLECULAR NETWORK GOVERNS INTESTINAL SMOOTH MUSCLE CELLS DIFFERENTIATION IN VERTEBRATES. Development, 144, 1-15, 2017.
  24. Xiaowen Chen, Dafne Gays, Carlo Millia and Massimo M. Santoro. CILIA CONTROL VASCULAR MURAL CELL RECRUITMENT IN VERTEBRATES. Cell Reports, 18, 1-15, 2017.
  25. Saravana K. Ramasamy, Anjali P. Kusumbe, Maria Schiller, Dagmar Zeuschner, M. Gabriele Bixel, Carlo Milia, Jaba Gamrekelashvili, Anne Limbourg, Alexander Medvinsky, Massimo M. Santoro, Florian P. Limbourg, and Ralf H. Adams. BLOOD FLOW CONTROLS BONE VASCULAR FUNCTION AND OSTEOGENESIS. Nature Communications. 7, 13601, 2016.
  26. Giulia Mana, Fabiana Clapero, Emiliano Panieri, Valentina Panero, Hui-Yuan Tseng, Federico Saltarin, Elena Astanina, Mark Morgan, Martin J. Humphries, Massimo M. Santoro, Guido Serini, and Donatella Valdembri. PPFIA1 DRIVES ACTIVE a5b1 INTEGRIN FIBRILLOGENESIS AND VASCULAR MORPHOGENESIS. Nature Communications. 7, 13546, 2016.
  27. Xiaowen Chen, Dafne Gays, and Massimo M. Santoro. TRANSGENIC ZEBRAFISH. Methods in Molecular Biology In Mitochondrial 1464, pp. 107–114, 2016
  28. Raj Sewduth and Massimo M. Santoro. “DECODING” ANGIOGENESIS: NEW FACETS
    CONTROLLING ENDOTHELIAL CELL BEHAVIOR. Frontiers in Physiology. 306, 1-7, 2016.
  29. Emiliano Panieri and Massimo M. Santoro. ROS HOMEOSTASIS AND METABOLISM: A
    DANGEROUS LIASON IN CANCER CELLS. Cell Death & Disease. e2253, 2016.
  30. Martano Chiara, Mugoni Vera, Dal Bello Federica, Santoro M. Massimo and Medana, Claudio. RAPID HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRY METHODOLOGY FOR MULTIPLE PRENOL LIPIDS ANALYSIS IN ZEBRAFISH EMBRYOS. Journal of Chromatography A, 1412, 59–66, 2015.
  31. Emiliano Panieri and Massimo M. Santoro. REDOX SIGNALING IN ENDOTHELIAL CELLS. Cell Mol Life Sci May, 72: 3281-303, 2015.
  32. Vitor Fortuna, Luc Pardanaud, Isabelle Brunet, Roxana Ola, Emma Ristori, Massimo M. Santoro, Stefania Nicoli, Anne Eichmann. VASCULAR MURAL CELLS INSTRUCT NORADRENERGIC DIFFERENTIATION OF EMBRYONIC SYMPATHETIC NEURONS. Cell Reports, 11: 2211-1247, 2015.
  33. Giulia Garaffo, Daniele Conte, Paolo Provero, Daniela Tomaiuolo, Zheng Luo, Patrizia Pinciroli, Clelia Peano, Ilaria Ilaria D’Atri, Yorick Gitton, Talya Etzion, Yoav Gothilf, Dafne Gays, Massimo M. Santoro, Giorgio Roberto Merlo. THE DLX5 AND FOXG1 TRANSCRIPTION FACTORS, LINKED VIA MIRNA-9 AND -200, ARE REQUIRED FOR THE DEVELOPMENT OF THE OLFACTORY AND GNRH SYSTEM. Mol Cell Neurosci. 68:103-119, 2015.
  34. Sonia Mercurio, Sara Petrillo, Deborah Chiabrando, Zuni Irma Bassi, Dafne Gays, Annalisa
    Camporeale, Andrei Vacaru, Barbara Miniscalco, Giulio Valperga, Lorenzo Silengo, Fiorella Altruda1, Margaret H Baron, Massimo M. Santoro and Emanuela Tolosano. HEME EXPORTER FLVCR1 REGULATES EXPANSION AND DIFFERENTIATION OF COMMITTED ERYTHROID PROGENITORS BY CONTROLLING INTRACELLULAR HEME ACCUMULATION. Hematologica, 100(6): 720-9, 2015.
  35. 5. Elisa De Luca, Gian Maria Zaccaria, Maura Hadhoud, Giovanna Rizzo, Roberto Ponzini, Umberto Morbiducci and Massimo M. Santoro. ZEBRABEAT: A FLEXIBLE PLATFORM FOR THE ANALYSIS OF THE CARDIAC RATE IN ZEBRAFISH EMBRYOS. Scientific Reports. 4, 4898, 2014.
  36. 6. Massimo M. Santoro. ZEBRAFISH AS A MODEL TO EXPLORING CELLULAR METABOLISM AND METABOLIC DISEASES. Trends in Endocrinology and Metabolism. 10, 546-54. 2014.
  37. Massimo M. Santoro. ANTI_ANGIOGENIC CANCER DRUGS USING THE ZEBRAFISH MODEL. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 1846, 2014.
  38. Giulia Garaffo, Paolo Provero, Ivan Molineris, Patrizia Pinciroli, Clelia Peano, Cristina Battaglia, Daniela Tomaiuolo, Talya Etzion, Yoav Gothilf, Massimo M. Santoro, and Giorgio R. Merlo. PROFILING, BIOINFORMATIC, AND FUNCTIONAL DATA ON THE DEVELOPING OLFACTORY/GNRH SYSTEM REVEAL CELLULAR AND MOLECULAR PATHWAYS ESSENTIAL FOR THIS PROCESS AND POTENTIALLY RELEVANT FOR THE KALLMANN SYNDROME.Frontiers in Endocrinology, 4, 203. 2014.
  39. Thomas R. Whitesell, Regan M. Kennedy, Alyson D. Carter, Evvi-Lynn Rollins, Sonja Georgijevic, Massimo M. Santoro and Sarah J. Childs. Α SMOOTH MUSCLE ACTIN (ACTA2/ΑSMA) ZEBRAFISH TRANSGENIC LINE MARKING VASCULAR MURAL CELLS AND VISCERAL SMOOTH MUSCLE CELLS. PloS One 9(3), e90590. 2014.
  40. Vera Mugoni, Annalisa Camporeale and Massimo M. Santoro. EXPLORING OXIDATIVE STRESS IN ZEBRAFISH EMBRYOS. JoVe 89, 2014.
  41. Vera Mugoni, Claudio Medana and Massimo M. Santoro. 13C-ISOTOPE BASED PROTOCOL FOR PRENYL LIPID METABOLIC ANALYSIS IN ZEBRAFISH TISSUES. Nature Protocols, 8, 2337-2347,2013.
  42. Carlo Follo, Matteo Ozzano, Claudia Montalenti, Massimo M. Santoro and Ciro Isidoro. KNOCKDOWN OF CATHEPSIN D IN ZEBRAFISH FERTILIZED EGGS DETERMINES CONGENITALMYOPATHY. BioScience Report, 33, 371-378, 2013.
  43. Massimo M. Santoro and Stefania Nicoli. miRNAs IN ENDOTHELIAL CELL SIGNALING: The endomiRNAs. Experimental Cell Research, 319, 1324-1330, 2013.
  44. Vera Mugoni, Ruben Postel, Valeria Catanzaro, Elisa De Luca, Giuseppe Digilio, Emilia Turco, Lorenzo Silengo, Michael P. Murphy, Claudio Medana, Didier Y. Stainier, Jeroen Bakkers and Massimo M. Santoro. UBIAD1 IS AN ANTIOXIDANT ENZYME THAT REGULATES eNOS ACTIVITY
    BY CoQ10 SYNTHESIS. Cell 152, 504–518, 2013.
  45. Dafne Gays and Massimo M. Santoro. THE AD-MIR-ABLE ADVANCES IN CARDIOVASCULAR BIOLOGY THROUGH THE ZEBRAFISH MODEL SYSTEM. Cell Mol Life Sci 70, 2489-2503, 2013.
  46. Massimo M. Santoro. “FISHING” FOR ENDOTHELIAL MICRORNA FUNCTIONS AND
    DYSFUNCTION. Vascular Pharmacology, 5, 60-68, 2011.
  47. Juanita Lopez, Sidonie Wicky John, Tencho Tenev, Gilles J. P. Rautureau, Mark G. Hinds, Floriana Francalanci, Rebecca Wilson, Meike Broemer, Massimo M. Santoro, Catherine L. Day and Pascal Meier. CARD-MEDIATED AUTOINHIBITION OF CIAP1’S E3 LIGASE ACTIVITY SUPPRESSES CELL PROLIFERATION AND MIGRATION. Molecular Cell, 42: 569–583, 2011.
  48. Carlo Follo, Matteo Ozzano, Vera Mugoni, Roberta Castino, Massimo M. Santoro and Ciro Isidoro. KNOCK-DOWN OF CATHEPSIN D AFFECTS THE RETINAL PIGMENT EPITHELIUM, IMPAIRS SWIM-BLADDER ONTOGENESIS AND CAUSES TO PRAECOX DEATH IN ZEBRAFISH. PLOSOne, 6(7):e21908, 2011.
  49. Adrian C. Grimes, Ana Carmen Durán, Valentin Sans-Coma, Danyal Hami, Massimo M. Santoro and Miguel Sanchez Torres. THE SECONDARY HEART FIELD AND CARDIAC OUTFLOW TRACT STRUCTURE: A PROPOSED COMMON THEME AMONG VERTEBRATES. Evolution & Development, 12:6, 552 –567, 2010.
  50. Massimo M. Santoro, Gabriella Pesce and Didier Y Stainier. CHARACTERIZATION OF VASCULAR MURAL CELLs DURING ZEBRAFISH DEVELOPMENT. Mechanisms of Development, 126: 638-49, 2009. Highlighted in Faculty of 1000.
  51. Jason E. Fish, Massimo M. Santoro, Sangho Yu, Didier Stainier and Deepak Srivastava. MIR-126, AN ENDOTHELIAL-SPECIFIC MICRORNA, REGULATES ANGIOGENESIS AND VASCULAR INTEGRITY BY TARGETING SPRED-1. Developmental Cell, 15: 272-284, 2008
  52. Mads Gyrd-Hansen, Maurice Darding, Maria Miasari, Massimo M. Santoro, Tencho Tenev, Paula da Fonseca, Marketa Zvelebil, Janusz M. Bujnicki, John Silke and Pascal Meier. IAPs CONTAIN AN EVOLUTIONARILY CONSERVED UBIQUITIN-BINDING DOMAIN THAT REGULATES NF-KB AS WELL AS CELL SURVIVAL AND ONCOGENESIS. Nature Cell Biology 10, 1309-1317, 2008.
  53. Massimo M. Santoro, Temesgen Samuel, Tracy Mitchel, John C. Reed and Didier Y. Stainier.
    BIRC2/IAP1 REGULATES ENDOTHELIAL CELL INTEGRITY AND BLOOD VESSEL
    HOMEOSTASIS. Nature Genetics 39, 1397 – 1402, 2007. News & views in Nature Genetics.
  54. Federica Chianale, Santina Cutrupi, Elena Rainero, Gianluca Baldanzi, Paolo E Porporato, Sara Traini, Nicoletta Filigheddu, Viola Gnocchi, Massimo M. Santoro, Ornella Parolini, Wim van Blitterswijk, Fabiola Sinigaglia and Andrea Graziani. DIACYLGLYCEROL KINASE-{ALPHA} MEDIATES HGF-INDUCED EPITHELIAL CELL SCATTER BY REGULATING RAC ACTIVATION AND MEMBRANE RUFFLING. Molecular Biology of the Cell 18, 4859 – 4871, 2007.
  55. Suk-Won Jin, Wiebke Herzog, Massimo M. Santoro, Tracy S Mitchell, Julie Frantsve, Benno
    Jungblut, Dimitris Beis, Ian C Scott, Leonard A D’Amico, Elke A Ober, Hether Verkade, Holly A Field, Neil C Chi, Anne Wehman, Hervig Baier, Didier Y. Stainier. A TRANSGENE-ASSISTED GENETIC SCREEN IDENTIFIES ESSENTIAL REGULATORS OF VASCULAR DEVELOPMENT IN VERTEBRATE EMBRYOS. Developmental Biology, 307:29 – 42, 2007.
  56. Serena Germano, Danilo Barberis, Massimo M. Santoro, Lorenza Penengo, Ami Citri, Yosef Yarden and Giovanni Gaudino. GELDANAMYCIN TRIGGERS A NOVEL RON DEGRADATIVE PATHWAY HAMPERING ONCOGENIC SIGNALLING. Journal of Biological Chemistry, 281 (31) 21710-9, 2006.
  57. Massimo M. Santoro and Giovanni Gaudino. CELLULAR AND MOLECULAR FACETS OF
    KERATINOCYTE REEPITHELIZATION DURING WOUND HEALING. Experimental Cell Research 304: 274-86, 2005.
  58. Massimo M. Santoro, Giovanni Gaudino and Emma Villa. PROTEIN PHOSPHATASE-1 BINDS TO PHOSPHOSERINE 1394 OF THE MSP RECEPTOR. Biochemical Journal, 376: 587-94, 2003
  59. Massimo M. Santoro, Giovanni Gaudino and Pier Carlo Marchisio. THE MSP RECEPTOR
    REGULATES α6β4 AND α3β1 INTEGRINS VIA 14-3-3 PROTEINS IN KERATINOCYTE REEPITHELIZATION. Developmental Cell, 5: 257-271, 2003.
  60. Claudia Camerino, Massimo M. Santoro, G. Mori, Pier Carlo Marchisio, Giovanni Gaudino, Antonia Zallone. C MACROPHAGE STIMULATING PROTEIN (MSP) REGULATE OSTEOBLAST DIFFERENTIATION AND ACTIVITY. Bone 30(3):34S-34S, 2002.
  61. Sandra Brunelleschi, Lorenza Penengo, Massimo M. Santoro and Giovanni Gaudino. RECEPTOR TYROSINE KINASES AS TARGET FOR ANTI-CANCER THERAPY. Current Pharmacological Design 8: 1959-72, 2002.
  62. Massimo M. Santoro, Lorenza Penengo, Sara Orecchia, Michele Cilli and Giovanni Gaudino. THE RON ONCOGENIC ACTIVITY INDUCED BY THE MEN2B-LIKE SUBSTITUTION OVERCOMES THE REQUIREMENT FOR THE MULTIFUNCTIONAL DOCKING SITE. Oncogene, 19: 5208-5211, 2000.
  63. Massimo M. Santoro, Lorenza Penengo, Marta Minetto, Sara Orecchia, Michele Cilli and Giovanni Gaudino. POINT MUTATIONS IN THE TYROSINE KINASE DOMAIN RELEASE THE ONCOGENIC AND METASTATIC POTENTIAL OF THE RON RECEPTOR. Oncogene, 17: 741-749, 1998.
  64. Massimo M. Santoro and Giovanni Gaudino. MOTOGENIC GROWTH FACTORS: HGF/SF AND MSP. Minerva Biotecnologica 9: 85-92, 1997.
  65. Massimo M. Santoro, Chiara Collesi, Silvia Grisendi, Giovanni Gaudino and Paolo Maria Comoglio. CONSTITUTIVE ACTIVATION OF THE RON GENE INDUCES INVASIVE GROWTH BUT NOT TRANSFORMATION. Molecular Cellular Biology 16: 7072-7083, 1996.
  66. Chiara Collesi, Massimo M. Santoro, Giovanni Gaudino and Paolo Maria Comoglio. A SPLICING VARIANT OF THE RON TRANSCRIPT INDUCES CONSTITUTIVE TYROSINE KINASE ACTIVITY AND INVASIVE PHENOTYPE. Molecular Cellular Biology 16: 5518-5526, 1996.
  67. Giovanni Gaudino, Antonia Follenzi, Luigi Naldini, Chiara Collesi, Massimo Santoro, Kathy A. Gallo, Paul J. Godowski and Paolo Maria Comoglio. RON IS A HETERODIMERIC TYROSINE KINASE RECEPTOR ACTIVATED BY THE HGFHOMOLOG MSP. EMBO Journal 13: 3524-3532, 1994.

 

Book Chapters

1.Dafne Gays, Vera Mugoni and Massimo M. Santoro. TUMOR ANGIOGENESIS: “FISHING” FOR DRUG SCREENING MODELS. Book title: “Angiogenesis and vascularisation – cellular and molecular mechanisms in health and diseases” Edited by Dr. Joseph Dulak. Springer series, 2014.

2.Vera Mugoni and Massimo M. Santoro. MANIPULATING REDOX SIGNALING TO BLOCK TUMOR ANGIOGENESIS. Book title: Research Directions in Tumor Angiogenesis Dr. Jianyuan Chai (Ed.) ISBN 978-953-51-0963-1. InTech Open, 2013.

3.Massimo M. Santoro. MODELING TUMOR ANGIOGENESIS IN ZEBRAFISH. Book Title: Tumor Angiogenesis, Sophia Ran (Ed.), pp167-180. ISBN: 978-953-51-0009-6, InTech Open. 2012.

4.Massimo M. Santoro. NEW FINDINGS IN GROWTH FACTOR RECEPTORS AND INTEGRINS CROSS-TALK. “Recent Research Developments in Molecular and Cellular Biology”, ISBN 81-308-0131-0, Vol.3, Part-II, Page 661-675, 2003.

5.Massimo M. Santoro and Giovanni Gaudino. THE CONSTITUTIVE ACTIVATION OF MET, RON, SEA GENES INDUCES DIFFERENT BIOLOGICAL RESPONSES. In “Interacting protein domains” NATOASI Series, Subseries H “Cell Biology”, ISBN 3-540-63124-0, vol. 102 Ed. by L. Heilmeyer, pp 207-212, Springer-Verlag Heidelberg, 1997.

MR. KEITH PAGAN

Mr. Keith Pagan studied Economics, American legal philosophy, and Physics at Princeton University, earning an A.B. degree in Economics and a certificate from the Program in American Studies. Following his studies at Princeton, he formed Nassau Partners, initially acting as a principal investor in residential and commercial real estate in Boston, Massachusetts, and then consulting to other real estate investors in San Francisco, California. In 1992, Mr. Pagan worked as an analyst and then a portfolio manager for BankAmerica Capital Corp., the venture capital affiliate of Bank of America, managing two proprietary securities portfolios valued at over $700 million. Later, he worked for Merrill Lynch, Salomon Smith Barney, and the Belvedere companies in investment management, focused on design and operation of both private hedge funds and public mutual funds and conducting investment banking.

Following the economic downturn in 2008, Mr. Keith Pagan studied costs law in England and Wales.

Mr. Keith Pagan has worked as a strategy consultant in the United States, focused on operations management and product development for firms experiencing changes in growth or requiring assistance with professional costs, such as legal, accounting, and other fees. His primary clients have been investment management firms and startup companies funded with venture capital.

Mr. Pagan is also an Engineer-in-Training at Geissler Engineering in San Francisco, California, and is pursuing in an eight-year apprentice program to become a Profession Engineer in structural engineering.

Mr. Pagan has been a guest lecturer at the Haas School of Business at the University of California, Berkeley. For nearly two decades, he has been a member of the Alumni Schools Committee, the group of alumni that interview the bulk of undergraduate applicants to Princeton University. Mr. Pagan is also a member of The Guardsmen, a volunteer group that enhances and improves the lives of at-risk youth in the San Francisco Bay Area.

Mr. Pagan is also a licensed land surveyor at Geissler Engineering in Incline Village in Nevada.

MRS. SALPI GEISSLER

Mrs. Salpi Geissler is a European Trademark Registrar.

Mrs. Salpi Geissler has applied to by Her Majesty’s government in Gibraltar to become a Commissioner-for-Oaths. This commission shall enable Mrs. Salpi Geissler to perform a key notary function, namely certifying as true and complete, copies of original documents and arranging for their legalization and/or Apostilles, depending on the jurisdiction where the certified copies are to be used. This is of great practical importance because in many jurisdictions neither attorneys nor notaries public are permitted to certify as true and complete, copies of original documents such as public records and academic transcripts. In many countries, this legal lacuna is filled by select diplomatic consular officers such as Honorary General Consuls or Adjunct Consuls.

Mrs. Salpi Geissler is trained as a family and civil mediator. She is available for both court-appointed and private mediations.

Mrs. Salpi Geissler is a member of the Corinthian Yacht Club of San Francisco, the Royal Swedish Yacht Club (Kungliga Svenska Segelsällskapet) and frequents the Yacht Club de Monaco.

Mrs. Salpi Geissler’s goal is to continue to serve the worldwide Armenian community in whatever capacity she is needed most.